Debt-to-Equity Ratio
Updated 294h ago
Sector Performance
53th percentileIVZ
0.77x
Sector Median
0.73x
Sector Avg
0.08x
Deep Analysis
The debt-to-equity ratio measures how much a company relies on borrowed money versus its own shareholder funds; a ratio of 0.77x means IVZ has $0.77 of debt for every $1 of equity, indicating moderate leverage.
This compares closely to the sector median of 0.73x, placing IVZ at the 53rd percentile among peers—slightly above the midpoint, meaning its leverage is near typical for the sector. The year-over-year change is not available, and the quarter-over-quarter change is also not available, so no trend can be assessed from the historical data provided. Because the current ratio is near the sector median and no trend information exists, the level alone suggests a neutral risk profile with no clear directional signal for increasing or decreasing leverage. This metric supports the overall NEUTRAL verdict, as the ratio does not indicate excessive debt or an unusually conservative capital structure that would change the investment outlook.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about IVZ?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
Who are IVZ's closest peers by Debt-to-Equity Ratio?
The closest peers by Debt-to-Equity Ratio include: ETSY (-2.62x), MCK (-3.00x), TDG (-3.40x), VRSK (-3.81x), MAR (-4.04x).
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master IVZ's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full IVZ research report →IVZ
0.77x
Sector Median
0.73x
Sector Avg
0.08x
How IVZ's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.